Monoclonal Antibodies (mAbs) Market Accelerates as Biologic Innovation Reshapes
Why This Matters Now Healthcare systems are moving toward therapies that target disease mechanisms with greater precision, and monoclonal antibodies are at the center of this shift. Pharma companies, biotech firms, hospitals, and investors are accelerating investment as demand grows …